Effects of Transcutaneous Electrical Nerve Stimulation (TENS) Following Hysterectomy

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Quality of Recovery After Abdominal Hysterectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03072888

Enrollment

Registered

2017-03-07

Start date

2016-03-31

Completion date

2017-05-05

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute

Keywords

acute pain, Transcutaneous Electric Nerve Stimulation, Anesthesia Recovery Period

Brief summary

The purpose of this study is to evaluate the effect of Transcutaneous Electrical Nerve Stimulation (TENS) in patients after abdominal hysterectomy surgery.

Detailed description

The aim of this study is to evaluate the efficacy of the Transcutaneous Electrical Nerve Stimulation (TENS) on postoperative pain and quality of recovery in patients following abdominal hysterectomy surgery under general anesthesia.

Interventions

DEVICETENS

Transcutaneous Electrical Nerve Stimulation will be apply

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients aged between18-65 undergoing elective abdominal hysterectomy * ASA (American Society of Anesthesiologist) I,II physical status

Exclusion criteria

* Not agreement with the study,Dermatological lesion affecting the electrode place, * Chronic or preprocedural use of opioids, steroids or psychoactive drugs, * Allergy to drugs used during trials, * Previous experience in TENS, * Kidney, liver, neurological or cardiovascular system disease * Body mass index\>40

Design outcomes

Primary

Measure	Time frame	Description
Quality of Recovery	At twenty-four hours after surgery	QoR-40 (Quality of Recovery 40) form will be used for evaluation

Secondary

Measure	Time frame	Description
Pain	During 24 hours after surgery	Dynamic and static pain will be evaluated by visual analog scale(VAS)
Analgesic Consumption	During 24 hours after surgery	Total consumption of analgesic will be recorded
Postoperative Nausea and Vomiting	During 24 hours after surgery	Nausea and Vomiting scores will be recorded

Other

Measure	Time frame	Description
Adverse events	During 24 hours after surgery	The number of adverse events will be recorded

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026